Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein

    360 million people are chronically infected with the human hepatitis B virus (HBV) and are consequently prone to develop liver cirrhosis and hepatocellular carcinoma1. As approved therapeutic regimens—which modul...

    Joerg Petersen, Maura Dandri, Walter Mier, Marc Lütgehetmann in Nature Biotechnology (2008)

  2. No Access

    Article

    RGB marking facilitates multicolor clonal cell tracking

    Kristoffer Weber et al. describe a new lentiviral vector-mediated RGB (red, green and blue) multicolor cell marking technique for analyzing clonal cell fates in vitro and in vivo. Here they use RGB marking to ass...

    Kristoffer Weber, Michael Thomaschewski, Michael Warlich, Tassilo Volz in Nature Medicine (2011)

  3. No Access

    Article

    Experimental models and therapeutic approaches for HBV

    Liver disease associated to persistent infection with the hepatitis B virus (HBV) continues to be a major health problem of global impact. In spite of the existence of an effective vaccine, approximately 360 m...

    Maura Dandri, Marc Lütgehetmann, Jörg Petersen in Seminars in Immunopathology (2013)

  4. Article

    Open Access

    New foe treated with old guns – supportive role of steroids in the treatment of acute severe hepatitis E

    Autochthonous hepatitis E has been observed with growing incidence in industrialized countries. Hepatitis E virus infection causes an acute hepatitis with spontaneous resolution in the majority of cases. Howev...

    Marcial Sebode, Sven Pischke, Marc Lütgehetmann, Susanne Polywka in BMC Gastroenterology (2014)

  5. No Access

    Article

    Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

    Inhibiting virus cell entry by targeting tight junctions cures HCV infection in mice.

    Laurent Mailly, Fei **ao, Joachim Lupberger, Garrick K Wilson in Nature Biotechnology (2015)

  6. No Access

    Chapter

    Experimental Models: Cell Culture and Animal Models

    Experimental models are indispensable tools for studying the biology of virus infection and for drug development. The narrow host range of hepatitis B virus (HBV), the lack of robust in vitro infection systems...

    Maura Dandri Ph.D., Tassilo Volz, Marc Lütgehetmann in Hepatitis B Virus in Human Diseases (2016)

  7. Article

    Open Access

    Attenuated viral hepatitis in Trem1−/− mice is associated with reduced inflammatory activity of neutrophils

    TREM1 (Triggering Receptor Expressed on Myeloid Cells 1) is a pro-inflammatory receptor expressed by phagocytes, which can also be released as a soluble molecule (sTREM1). The roles of TREM1 and sTREM1 in live...

    Jan-Hendrik Kozik, Tanja Trautmann, Antonella Carambia, Max Preti in Scientific Reports (2016)

  8. No Access

    Protocol

    Immunofluorescent Staining for the Detection of the Hepatitis B Core Antigen in Frozen Liver Sections of Human Liver Chimeric Mice

    The hepatitis B virus (HBV) is the causative agent for chronic hepatitis B infection, which affects an estimate of 240 million people worldwide and puts them at risk of develo** terminal liver disease. The l...

    Lena Allweiss, Marc Lütgehetmann, Maura Dandri in Hepatitis B Virus (2017)

  9. Article

    Open Access

    Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice

    Co-infection with hepatitis B (HBV) and D virus (HDV) is associated with the most severe course of liver disease. Interferon represents the only treatment currently approved. However, knowledge about the impac...

    Katja Giersch, Maria Homs, Tassilo Volz, Martina Helbig in Scientific Reports (2017)

  10. No Access

    Article

    Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center

    To determine epidemiological, clinical and laboratory characteristics of leptospirosis, 24 consecutive patients diagnosed with the infection between 2011 and 2017 at the University Medical Center Hamburg-Eppen...

    Thomas Theo Brehm, Julian Schulze zur Wiesch, Marc Lütgehetmann, Dennis Tappe in Infection (2018)

  11. Article

    Open Access

    DAMIAN: an open source bioinformatics tool for fast, systematic and cohort based analysis of microorganisms in diagnostic samples

    We describe DAMIAN, an open source bioinformatics tool designed for the identification of pathogenic microorganisms in diagnostic samples. By using authentic clinical samples and comparing our results to those...

    Malik Alawi, Lia Burkhardt, Daniela Indenbirken, Kerstin Reumann in Scientific Reports (2019)

  12. Article

    Open Access

    High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort

    Chronic hepatitis delta virus (HDV) infection causes severe liver disease which often leads to cirrhosis and hepatocellular carcinoma (HCC). Aim of this study was to establish the disease severity and prognost...

    Jan-Hendrik Bockmann, Marcel Grube, Vanessa Hamed in BMC Gastroenterology (2020)

  13. Article

    Open Access

    Implementation of the FilmArray ME panel in laboratory routine using a simple sample selection strategy for diagnosis of meningitis and encephalitis

    Infectious meningitis is a serious disease and patient outcome relies on fast and reliable diagnostics. A syndromic panel testing approach like the FilmArray ME can accelerate diagnosis and therefore decrease ...

    Susanne Pfefferle, Martin Christner, Martin Aepfelbacher in BMC Infectious Diseases (2020)

  14. Article

    Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany

    Autopsies of deceased with a confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can provide important insights into the novel disease and its course. Furthermore, autopsies are es...

    Carolin Edler, Ann Sophie Schröder in International Journal of Legal Medicine (2020)

  15. Article

    Correction to: Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany

    The affiliation of the author Martin Aepfelbacher was incorrectly assigned in the manuscript. Martin Aepfelbacher is affiliated to the Institute of Microbiology, University Medical Center Hamburg-Eppendorf, Ha...

    Carolin Edler, Ann Sophie Schröder in International Journal of Legal Medicine (2020)

  16. Article

    Open Access

    Germany’s first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection

    Clinical characterization of COVID-19 (Corona Virus Disease 2019) is being performed worldwide to gain insights into the pathogenesis and course of the disease. Little is known regarding morphological findings...

    Fabian Heinrich, Jan-Peter Sperhake, Axel Heinemann, Herbert Mushumba in Virchows Archiv (2020)

  17. Article

    Open Access

    Antibiotic sensitivity in correlation to the origin of secondary peritonitis: a single center analysis

    Despite improvements in diagnosis, intensive-care medicine and surgical technique, the mortality of patients with secondary peritonitis is still high. Early and aggressive empiric antibiotic treatment has stro...

    Rainer Grotelüschen, Lena M. Heidelmann, Marc Lütgehetmann in Scientific Reports (2020)

  18. Article

    Open Access

    Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients

    Marcel S. Woo, David Steins, Vivien Häußler, Matin Kohsar in Journal of Neurology (2021)

  19. Article

    Open Access

    Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza

    While several studies have described the clinical course of patients with coronavirus disease 2019 (COVID-19), direct comparisons with patients with seasonal influenza are scarce. We compared 166 patients with...

    Thomas Theo Brehm, Marc van der Meirschen, Annette Hennigs in Scientific Reports (2021)

  20. Article

    Open Access

    Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect?

    SARS-CoV-2 caused a pandemic and global threat for human health. Presence of liver injury was commonly reported in patients with coronavirus disease 2019 (COVID-19). However, reports on severe liver dysfunctio...

    Kevin Roedl, Dominik Jarczak, Andreas Drolz, Dominic Wichmann in Annals of Intensive Care (2021)

previous disabled Page of 2